This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Karo Pharma Dividend
Dividend criteria checks 0/6
Key information
0%
Dividend yield
0%
Payout ratio
| Industry average yield | 2.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -kr0.69 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 0RAQ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 0RAQ's dividend payments have been increasing.
Dividend Yield vs Market
| Karo Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (0RAQ) | 0% |
| Market Bottom 25% (GB) | 2.2% |
| Market Top 25% (GB) | 6.0% |
| Industry Average (Pharmaceuticals) | 2.7% |
| Analyst forecast in 3 Years (0RAQ) | n/a |
Notable Dividend: Unable to evaluate 0RAQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 0RAQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 0RAQ is not paying a notable dividend for the UK market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 0RAQ has not reported any payouts.